About Trichem Pharmascience
Trichem Pharmascience is a company based in Mumbai (India) founded in 1998 was acquired by IMCD in June 2025. Trichem Pharmascience offers products and services including Clindamycin HCl, Paclitaxel IP, Gemcitabine HCl, and Doxorubicin HCl. Trichem Pharmascience operates in a competitive market with competitors including Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
- Headquarter Mumbai, India
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Trichem Pharmascience Llp
- Jurisdiction Mumbai, Maharashtra, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Trichem Pharmascience
Trichem Pharmascience offers a comprehensive portfolio of products and services, including Clindamycin HCl, Paclitaxel IP, Gemcitabine HCl, and Doxorubicin HCl.
Antibiotic API used in pharmaceutical formulations.
Chemotherapy API for cancer treatment applications.
Anticancer API for medical and therapeutic use.
Antibiotic and chemotherapy API for oncology.
Funding Insights of Trichem Pharmascience
Detailed funding history for Trichem Pharmascience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Trichem Pharmascience
Trichem Pharmascience has secured backing from 1 investor. Prominent investors backing the company include IMCD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Speciality chemicals and food ingredients are distributed by IMCD.
|
Locked | Locked | Locked |
Investor details for Trichem Pharmascience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Trichem Pharmascience
Investment portfolio details for Trichem Pharmascience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Trichem Pharmascience
Detailed financials for Trichem Pharmascience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Trichem Pharmascience Comparisons
Peer comparison for Trichem Pharmascience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Trichem Pharmascience
Trichem Pharmascience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
APIs and intermediates are manufactured by Viyash as a CDMO.
|
|
| Locked | Locked | Locked |
Actives, advanced intermediates, and specialty chemicals are custom manufactured.
|
|
| Locked | Locked | Locked |
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
|
|
| Locked | Locked | Locked |
Advanced API intermediates are manufactured for pharmaceutical use.
|
|
| Locked | Locked | Locked |
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO.
|
|
| Locked | Locked | Locked |
CDMO focused on manufacturing of APIs and intermediates
|
Detailed competitors of Trichem Pharmascience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Trichem Pharmascience
Complete news archive for Trichem Pharmascience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trichem Pharmascience
Trichem Pharmascience was founded in 1998.
Trichem Pharmascience is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Trichem Pharmascience LLP was founded in 1998 and is headquartered in Mumbai, India. Operations focus on the pharmaceutical sector, where specialty chemicals and intermediates are manufactured for various industries. Expertise is held in facility maintenance products and coatings, with applications in high-heat and high-pressure environments. A presence is maintained across India, ensuring products and services meet industry standards.
Trichem Pharmascience's top competitors include Inventys, Viyash and Blue Jet Healthcare.
Trichem Pharmascience offers Clindamycin HCl, Paclitaxel IP, Gemcitabine HCl, and Doxorubicin HCl.
Trichem Pharmascience has 1 investor. Key investors include IMCD.